Skip to Main Content

Paper Details

A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants.
medRxiv
0
2022
Author NameAffiliation
Ana S Gonzalez-ReicheIcahn School of Medicine at Mount Sinai
Robert SebraIcahn School of Medicine at Mount Sinai
Robert Sebra
Robert SebraBlack Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai
Robert SebraIcahn Genomics Institute, Icahn School of Medicine at Mount Sinai
Robert SebraIcahn School of Medicine at Mount Sinai
Robert SebraIcahn Genomics Institute, Icahn School of Medicine at Mount Sinai
Robert SebraBlack Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai
Robert Sebra
Viviana SimonIcahn School of Medicine at Mount Sinai
Viviana SimonIcahn School of Medicine at Mount Sinai
Viviana SimonCenter for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai
Viviana SimonIcahn School of Medicine at Mount Sinai
Viviana SimonThe Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Harm van BakelIcahn School of Medicine at Mount Sinai
Harm van BakelIcahn Genomics Institute, Icahn School of Medicine at Mount Sinai
Harm van BakelIcahn School of Medicine at Mount Sinai
Harm van BakelIcahn Genomics Institute, Icahn School of Medicine at Mount Sinai
Emilia Mia SordilloIcahn School of Medicine at Mount Sinai
  • 1 - 19

Datasets